Host-pathogen interactions: A biological rendez-vous of the infectious nonself and danger models?

PLoS Pathogens

Volumn 2, Issue 5, 2006, Pages 341-345

  Tournier, Jean Nicolas ^a   Quesnel Hellmann, Anne ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; AUTOIMMUNITY; CELL SURVIVAL; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; NONHUMAN; NOTE; TISSUE INJURY; ANIMAL; BIOLOGICAL MODEL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFECTION; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; IMMUNE SYSTEM; INFECTION; MODELS, IMMUNOLOGICAL;

EID: 33646942975     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0020044     Document Type: Note

References (55)

1. Metchnikof E (1895) Etudes sur l'immunité: Sur la destruction extracellulaire des bactéries dans l'organisme. (sixième mémoire). Ann Institut Pasteur Paris 9: 433-461.
2. Janeway CA (1998) Presidential address to the American association of immunologists. The road less traveled by: The role of innate immunity in the adaptive response. J Immunol 161: 539-544.
3. Janeway CA (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54: 1-13.
4. Medzhitov R, Brenton-Hurlburt P, Janeway CA (1997) A human homologue of the Drosophila Toll protein signals activation adaptive immunity. Nature 388: 394-396.
5. Janeway CA (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13: 11-16.
6. Medzhitov R, Janeway CA Jr (2002) Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
7. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
8. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A (2005) Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6: 769-776.
9. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, et al. (2005) Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11: 138-145.
10. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, et al. (2005) Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202: 321-331.
11. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1046.
12. Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Curr Opin Immunol 13: 114-119.
13. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, et al. (2000) Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191: 423-433.
14. Seong SS, Matzinger P (2004) Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4: 469-478.
15. Rosenberger CM, Finlay BB (2003) Phagocyte sabotage: Disruption of macrophages signalling by bacterial pathogens. Nat Rev Mol Cell Biol 4: 385-396.
16. Finlay BB, McFadden EP (2006) Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 124: 767-782.
17. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4: 499-511.
18. Akira S, Uematsu S, Takeuchi H (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
19. Hornef MW, Wick MJ, Rhen M, Normak S (2002) Bacterial strategies for overcoming host innate and adaptive immune response. Nat Immunol 3: 1033-1040.
20. Katze MG, He Y, Gale M Jr (2002) Viruses and interferon: A fight for supremacy. Nat Rev Immunol 2: 675-687.
21. Moynagh PN (2005) TLR signalling and activation of IRFs: Revisiting old friends from the NF-κB pathway. Trends Immunol 26: 469-476.
22. Kawai T, Akira S (2006) Innate immune recognition of viral infection. Nat Immunol 7: 131-137.
23. Seth RB, Sun B, Chen ZJ (2006) Antiviral innate immunity pathways. Cell Res 16: 141-147.
24. Bowie A, Kiss-Toth E, Symons JA, Smith GL, Dower SK, et al. (2000) A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97: 10162-10167.
25. Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, et al. (2005) Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201: 1007-1018.
26. Harte MT, Haga IR, Maloney G, Gray P, Reading PC, et al. (2003) The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 197: 343-351.
27. Smith EJ, Marie I, Prakash A, Garcia-Sastre A, Levy DE (2001) IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or IκB kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 276: 8951-8957.
28. Xiang Y, Condit RC, Vijaysri S, Jacobs B, Williams BR, et al. (2002) Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. J Virol 76: 5251-5259.
29. Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352: 739-745.
30. Dang O, Navarro L, Anderson K, David M (2004) Cutting edge: Anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide. J Immunol 172: 747-751.
31. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, et al. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
32. Tournier JN, Quesnel-Hellmann A, Mathieu J, Montecucco C, Tang WJ, et al. (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 174: 4934-4941.
33. Navarro L, Alto NM, Dixon JE (2005) Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr Opin Microbiol 8: 21-27.
34. Boyer L, Lemichez E (2006) Targeting of host-cell ubiquitin and ubiquitin-like pathways by bacterial factors. Nat Rev Microbiol 2: 779-788.
35. Fink SL, Cookson BT (2005) Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infect Immun 73: 1907-1916.
36. Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: Viral evasion of apoptosis. Nat Immunol 3: 1013-1018.
37. Hay S, Kannourakis G (2002) A time to kill: Viral manipulation of the cell death program. J Gen Virol 83: 1547-1564.
38. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, et al. (1999) Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J Immunol 163: 6762-6768.
39. Humlova Z, Vokurka M, Esteban M, Melkova Z (2002) Vaccinia virus induces apoptosis of infected macrophages. J Gen Virol 83: 2821-2832.
40. Park JM, Greten FR, Li ZW, Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297: 2048-2051.
41. Popov SG, Villasmil R, Bernardi J, Grene E, Cardwell J, et al. (2002) Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem Biophys Res Commun 293: 349-355.
42. Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, et al. (2004) Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J Immunol 173: 3320-3328.
43. Mills SD, Boland A, Sory MP, van der Smissen P, Kerbourch C, et al. (1997) Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc Natl Acad Sci U S A 94: 12638-12643.
44. Monack DM, Mecsas J, Ghori N, Falkow S (1997) Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 94: 10385-10390.
45. Monack DM, Mecsas J, Bouley D, Falkow S (1998) Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188: 2127-2137.
46. Denecker G, Declercq W, Geuijen CA, Boland A, Benabdillah R, et al. (2001) Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J Biol Chem 276: 19706-19714.
47. Henson PM, Bratton DL, Fadok VA (2001) The phosphatidylserine receptor: A crucial molecular switch? Nat Rev Mol Cell Biol 2: 627-633.
48. Voll RE, Hermann M, Roth EA, Stach C, Kalden JR (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
49. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, et al. (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 101: 890-898.
50. Huynh ML, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 109: 41-50.
51. Kim S, Elkon KB, Ma X (2004) Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21: 643-653.
52. Albert ML (2004) Death-defying immunity: Do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 4: 223-231.
53. Albert ML, Jegathesan M, Darnell RB (2001) Dendritic cell maturation is required for the cross-tolerization of CD8+ cells. Nat Immunol 2: 1010-1017.
54. Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, et al. (2002) Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic b cells. Immunity 16: 169-181.
55. Hahm B, Arbour N, Oldstone MB (2004) Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 323: 292-302.